Bharat Immunologicals & Biologicals Corporation

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue26.800.108.140.100.16
Expenses30.766.4313.826.076.81
EBITDA-2.18-4.62-3.53-4.22-4.53
EBIT-2.22-4.66-3.62-4.25-4.56
Profit Before Tax-3.96-6.33-5.68-5.97-6.65
Net Profit-3.08-4.68-3.88-4.59-4.92
Financial Ratios
Operating Profit Margin-8.23%0.00%-46.14%0.00%0.00%
Net Profit Margin-11.63%0.00%-50.72%0.00%0.00%
Earning Per Share (Diluted)-0.71-1.08-0.90-1.06-1.14
Dividends Per Share0.000.000.000.000.00